Eng

Valium

Quick links to important sections

Valium

Selected form

Diazepam

Method of action: Antianxiety, Anticonvulsant, Anxiolytic, Hypnotic, Muscle Relaxant, Psycholeptics, Sedative, Tranquilizing

Treatment option: Alcoholism, Alcohol Dependence And Withdrawal, Arteriosclerosis/Atherosclerosis, Delirium Tremens, Insomnia, Pain, Delirium, Hypertension, Headache, Muscle Cramp

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Valium

Property	Description
Active ingredient	Diazepam
Form	Tablet, Oral Solution, Injection, Rectal Gel, Nasal Spray
Pharmacological class	Benzodiazepine (Central Nervous System Depressant)
General purpose	Achieve stability and relaxation by calming overactive nerves
Origin	Synthetic (Benzodiazepine derivative)

Valium is the established brand name for the prescription-only medicine containing the active ingredient diazepam, which functions as a Central Nervous System (CNS) depressant. This medication is fundamentally characterized as a synthetic benzodiazepine derivative that provides comprehensive control over nerve excitability.

What is Valium (Diazepam) and What Type of Drug Is It?

Valium's active substance is diazepam, a classic synthetic compound that belongs to the benzodiazepine class of psychotropic drugs. This classification means it is chemically designed to modify brain activity, specifically acting on the inhibitory GABA system to slow down excessive nerve signaling. Diazepam has an established clinical role in relieving anxiety and muscle spasms. Its core identity is defined by its application as an anxiolytic, a sedative, and a potent skeletal muscle relaxant. The compound is characterized by a predictable profile as a long-acting agent, differentiating it from shorter-acting benzodiazepines.

Forms and General Purpose of Diazepam

Diazepam is a single-ingredient product available in multiple dosage forms to suit varying clinical needs. These include the standard oral tablet and oral solution, as well as specialized preparations like solution for injection and rectal gel or the nasal spray formulation. This versatility allows for various routes of administration, such as oral or rapid intravenous (IV) delivery, making it adaptable for acute situations. The medication is utilized for its clinical utility and its potent anticonvulsant properties, playing a role in the management of severe, time-sensitive symptoms. The overall therapeutic purpose of the drug is to achieve a state of stability by calming overactive nerves, offering the benefit of restoring neurological balance.

Regulatory References

World Health Organization

What side effects are possible with Valium?

Possible Side Effects and Safety Information

Diazepam's (Valium) safety profile is defined by its core action as a Central Nervous System (CNS) depressant. The most frequently reported adverse reactions affect the CNS and are classified according to frequency in regulatory documents.

Frequency-Classified Adverse Reactions

Classification	Examples of Officially Listed Effects
Very Common	Drowsiness
Common	Ataxia (loss of coordination), Fatigue, Confusion, Impaired motor ability
Uncommon	Respiratory depression, Anterograde amnesia, Slurred speech (dysarthria)
Rare	Respiratory arrest, Jaundice, Paradoxical reactions (e.g., aggression), Cardiac arrest, Hypotension

Serious Safety Constraints and Dependence Risk

Regulatory warnings emphasize the significant risk of developing physical and psychological dependence, particularly with increased dose and duration of use. Abrupt cessation after dependence has developed may result in a severe withdrawal syndrome. The medicine is associated with a critical, life-threatening risk of profound sedation and respiratory depression, especially when used concomitantly with opioids, leading to mandated warnings against co-administration in official labels. The medicine is contraindicated in patients with conditions such as severe hepatic insufficiency, myasthenia gravis, and severe respiratory insufficiency.

Population-Specific Safety Considerations

The label specifies that older adults are more susceptible to CNS effects like sedation and ataxia, which elevates the risk of falls and injury. Furthermore, use late in pregnancy is associated with risks to the newborn, including neonatal withdrawal symptoms and 'floppy infant syndrome.'

Overdose and Emergency Response

Overdose and When to Seek Help

Immediate medical attention must be sought for any suspected overdose.

Regulatory documents characterize overdose primarily as a progression of Central Nervous System (CNS) depression. Symptoms typically seen in overdose include somnolence, confusion, lethargy, and ataxia (loss of full control of bodily movements). More serious presentations involve diminished reflexes, hypotension, and varying degrees of impaired consciousness, potentially progressing to a light coma.

While an overdose of Valium alone is generally not life-threatening, the risk of severe complications increases significantly when it is combined with other CNS depressants, particularly alcohol. This co-ingestion can lead to cardiorespiratory collapse and may result in a fatal outcome.

Official Emergency Response

In the event of an overdose, management typically involves supportive measures, including close monitoring of vital signs such as respiration, pulse rate, and blood pressure. Procedural instructions often include immediate administration of activated charcoal or gastric lavage. The use of the benzodiazepine antagonist flumazenil may be considered; however, its administration carries a documented risk of precipitating seizures.

Due to the risk of severe cardiorespiratory compromise, especially with co-ingestion, contact emergency services immediately.

Therapeutic Uses of Valium

Valium (diazepam) is used for the symptomatic relief of conditions marked by symptoms of increased neurological or muscular activity and is indicated for easing distressing symptoms across several therapeutic contexts.

The medication is commonly used to help with symptom clusters that may become intense or disruptive, such as excessive worry and restlessness associated with anxiety, relief for painful muscle spasms and spasticity, and stabilization during acute scenarios like sustained seizures and alcohol withdrawal syndrome. It is often applied during phases when symptoms become more noticeable, particularly in conditions characterized by periods of heightened symptoms or functional instability.

Quick Fact

Quick Fact: Relief for Anxiety, Spasm, and Acute Seizures

Valium provides support that helps ease the overall symptom burden in situations involving certain distressing symptoms, assisting with maintaining a sense of stability when symptoms interfere with routine activities.

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Regulatory authorities define eligibility for Valium (diazepam) through specific contraindications and age restrictions.

Populations Contraindicated for Use

Valium must not be used in patients with the following conditions, as formally stated in regulatory labeling:

Known Hypersensitivity to diazepam or any other benzodiazepine.
Severe Hepatic Insufficiency or severe liver disease (risk of hepatic encephalopathy).
Severe Respiratory Insufficiency (risk of respiratory depression).
Myasthenia Gravis (risk of exacerbating muscle weakness).
Sleep Apnea Syndrome.
Acute Narrow-Angle Glaucoma.

Age-Related Eligibility

Age Group	Eligibility Status (Official Labeling)
Infants (< 6 months)	Contraindicated (Lack of clinical experience)
Children (ge 6 months)	Allowed for specific, documented indications.
Older Adults	Conditional Use (Lower dose recommended due to increased sensitivity).

Use in Pregnancy and Lactation

Use during Pregnancy is restricted and considered only when the clinical situation warrants the potential risk to the fetus, particularly non-teratogenic risks like neonatal flaccidity if used late in pregnancy. The drug is generally not recommended during Lactation as diazepam passes into breast milk, posing a risk of infant sedation and feeding difficulties.

What should I know about interactions with other medicines?

Valium Interactions with other medicines and products

Interaction Severity Classification: High Risk for Co-administration

Valium (diazepam) has two primary interaction profiles: pharmacodynamic (additive central nervous system effects) and pharmacokinetic (metabolic interference).

High-Risk Combination:

Opioids and other Central Nervous System (CNS) Depressants: Co-administration with opioids (e.g., hydrocodone, oxycodone), alcohol, or other CNS depressants (e.g., barbiturates, other benzodiazepines, sedative antihistamines, or certain antipsychotics) carries a severe risk of profound sedation, respiratory depression, coma, and death. Official regulatory labeling carries the strongest caution (a Boxed Warning) against this use, requiring the lowest effective doses and minimum durations when no alternative treatment is adequate.

Pharmacokinetic Interactions:

Enzyme Inhibitors: Diazepam is metabolized primarily by the liver enzymes CYP2C19 and CYP3A4. Medicinal products that inhibit these enzymes (e.g., cimetidine, fluvoxamine, fluoxetine, omeprazole, ketoconazole) can decrease the rate of diazepam elimination, leading to higher blood concentrations and potentially increased sedative effects.
Enzyme Inducers: Conversely, medicines that induce these enzymes (e.g., rifampin, carbamazepine, phenytoin) may increase the rate of diazepam elimination, potentially reducing its effectiveness.

Patients should be advised against the simultaneous ingestion of alcohol and other CNS-depressant drugs due to the enhanced risk of adverse effects.

Mechanism of Action

How Diazepam Works

The primary mechanism of action of diazepam is centered on its interaction with the GABA-A receptor in the central nervous system. Diazepam functions as a positive allosteric modulator, binding to a specific GABA-A receptor subunit interface, typically between the alpha and gamma subunits . This binding enhances the affinity and effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).

This allosteric modification does not directly activate the receptor. Instead, the resulting conformational change promotes increased receptor sensitivity to GABA. The amplified GABA effect leads to an increased frequency of the integral chloride ion channel opening. The subsequent influx of negatively charged chloride ions ( Cl^-) across the neuronal membrane causes the cell to hyperpolarize. This change in membrane potential ultimately decreases the probability of action potential generation, contributing to the overall modulation of neural network signaling.

Dosage and Administration Information

Diazepam is subject to specific parameters governing its route, dose, frequency, and preparation. The medication is available for oral administration (tablets and solutions), as well as parenteral injection (IV or IM), and specialized forms like rectal gel or nasal spray for acute intermittent use.

Standard Labeled Dosing Regimens (Adults)

Indication	Typical Oral Dose	Frequency
Anxiety	2 mg to 10 mg	2 to 4 times a day
Muscle Spasm	2 mg to 10 mg	3 to 4 times a day

For acute situations like Status Epilepticus, the intravenous (IV) dose is typically 5 mg to 10 mg, which can be repeated up to a cumulative maximum of 30 mg. IV administration is performed slowly, at a rate not exceeding 5 mg per minute, and the IV solution is not to be mixed with other drugs or solutions.

The drug is generally intended for short-term use. Acute intermittent use (such as rectal or nasal forms for seizure clusters) is subject to specific frequency limits, restricted to no more than one episode every five days and a maximum of five episodes per month.

Special Administration Rules:

Oral absorption can be delayed and decreased when administered with a moderate fat meal.
For older adults, the initial dose is generally reduced to 2 mg to 2.5 mg, given once or twice daily, due to altered clearance patterns.

Recent Clinical Evidence

Research evidence / Overview of Studies for Valium

Evidence for Acute Symptom Management

Research exploring the use of diazepam for outcomes related to short-term anxiety symptoms or managing skeletal muscle spasms primarily consists of short-term Randomized Controlled Trials (RCTs). These studies were conducted during periods of increased symptom activity and evaluated changes in symptom severity scores or functional mobility. For acute repetitive seizures and acute alcohol withdrawal syndrome, the evidence base includes RCTs and Comparative Clinical Trials evaluated in emergency settings, focusing on outcomes like time-to-seizure cessation and the monitoring of complications over acute periods. Findings describing patterns observed in these studies generally focus on short-term changes and acute responses.

Long-Term Outcomes and Research Limitations

The majority of the evidence was evaluated in settings assessing short-term or episodic symptom patterns. This means long-term effects are not fully established regarding the durability of any observed response or the evolution of outcomes over extended periods. Research often highlights that follow-up durations were limited in initial studies, and certainty remains low when considering outcomes beyond a few weeks of use. Data for certain groups remain insufficient, particularly for patients with complex comorbidities or specific age subgroups, such as very young children. Research is still exploring the full profile of long-term effects, including those related to tolerance and dependency-related outcomes. The results apply only to the populations studied in trials, and the research provides context but not individual predictions.

Key Studies & References

How should Valium be stored and disposed of?

Official Storage and Disposal Requirements for Valium (Diazepam)

Requirement Category	Official Regulatory Mandate
Storage Conditions	Store at room temperature; keep the container tightly closed and in its original container
Environmental Control	Protect from excess heat and moisture; avoid storage in locations like the bathroom
Child Safety	Must be kept out of sight and reach of children using locked safety caps
Disposal Protocol	The preferred method is a drug take-back program or mail-back envelope
Special Disposal Rule	Diazepam rectal gel is an exception and must be immediately flushed down the toilet if a take-back option is unavailable, due to the high risk of accidental exposure

These official rules ensure product stability and prevent accidental ingestion. When disposing of unneeded product that is not the rectal gel, mix the medicine with an undesirable substance, seal it, and place it in the household trash if a take-back program is inaccessible.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.